Skip to main content

Table 4 Cost-effectiveness analysis results (US$)

From: The Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA

Outcome Lisdexamfetamine dimesylate No pharmacotherapy Difference
Total cost $7,041.92 $6,866.52 $175.41
QALY 0.9171 0.9108 0.0064
ICER    $27,617.56
Average costs per patient
 Drug $541.82 $0.00 $541.82
 Primary carea $869.31 $903.66 −$34.35
 Out-patient careb $657.62 $699.43 −$41.80
 Emergency room $288.58 $307.12 −$18.54
 Hospitalization $4,659.70 $4,956.31 −$296.61
 Adverse events $24.89 $0.00 $24.89
  1. ICER incremental cost-effectiveness ratio, QALY quality-adjusted life year
  2. aCosts of general internist/family doctor visit and nurse practitioner visit
  3. bCosts of gynecologist visit (only for women), psychiatrist visit, psychologist visit, and psychotherapist visit